secwatch.observer — SEC 8-K summary
======================================

Issuer:     Philip Morris International Inc. (PM)
CIK:        0001413329
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001413329-25-000011
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMI: FY2024 adj. diluted EPS $6.57 (+9.3%); reported EPS $4.52; smoke-free 40% of net revenue
--------------------------------------------------------------------------------

- FY2024 reported diluted EPS $4.52; adjusted diluted EPS $6.57 (+9.3%, +15.6% currency-neutral); $6.01 before Canada impairment $1.49.
- Smoke-free business: FY net revenues +14.2% (+16.7% organic); gross profit +18.7% (+22.7% organic); now 40% of total net revenues, 42% of gross profit.
- IQOS HTU adjusted IMS volume +12.6% full year; Q4 +~13%; ILUMA i driven double-digit growth in Japan; HTU >50% nicotine offtake share in 10 major cities.
- FDA authorized all ZYN pouches in U.S.; PMI hopes other pending FDA applications accelerated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1413329/000141332925000011/0001413329-25-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1413329/000141332925000011/pm-20250206.htm
  HTML page:      https://secwatch.observer/filing/0001413329-25-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer